ArticleFrontiers in immunology2022

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis.

Sara Remuzgo-Martínez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.